Hims & Hers CCO executes options, sells 250 shares under 10b5-1 plan

Rhea-AI Filing Summary

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc. (HIMS), reported option exercise and an immediate sale under a pre-existing trading plan. On 10/01/2025 he exercised 250 stock options at an exercise price of $11.53 per share and sold 250 shares at $56.00 per share. After these transactions his reported beneficial ownership of Class A common stock was 291,439 shares and he holds 47,106 stock options outstanding. The Form 4 states the trades were made pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025, and that the options vest monthly over a four-year service period beginning April 1, 2023.

Positive

• Transactions effected under a documented Rule 10b5-1 plan, adopted March 4, 2025, indicating pre-arranged trading
• Realized gain per share from exercise to sale ($11.53 exercise vs $56.00 sale)

Negative

• Immediate sale of exercised shares could be viewed as partial liquidation of insider holdings
• Options subject to multi-year service vesting, delaying further dilution until vesting occurs

Insights

Insider Transactions Analyst

Insider exercised 250 options at $11.53 and sold 250 shares at $56 on 10/01/2025 under a 10b5-1 plan.

The filing shows a routine liquidity event where Michael Chi converted options into shares and immediately sold the same number of shares, realizing the difference between the $11.53 exercise price and the $56.00 sale price.

The trades were executed under a documented Rule 10b5-1 plan adopted on March 4, 2025, which the filer discloses to indicate pre-arranged timing rather than opportunistic trading.

Equity Ownership Specialist

Post-transaction holdings remain large: 291,439 shares and 47,106 options outstanding.

The report lists beneficial ownership after the transactions as 291,439 Class A shares and 47,106 stock options, indicating continued substantial equity exposure despite the sale.

The options retain a service-based vesting schedule over four years starting April 1, 2023, which ties additional future share availability to continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Chi Michael

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/01/2025		M(1)		250	A	$11.53	291,689	D
Class A Common Stock	10/01/2025		S(1)		250	D	$56	291,439	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$11.53	10/01/2025		M(1)			250	(2)	03/01/2033	Class A Common Stock	250	$0	47,106	D

Explanation of Responses:

1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

2. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Michael Chi	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for HIMS?

The Form 4 was filed on behalf of Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc. (HIMS).

What transactions were reported on 10/01/2025 for HIMS?

On 10/01/2025, 250 stock options were exercised at $11.53 per share and 250 shares were sold at $56.00 per share.

Were the trades part of a trading plan?

Yes. The filing states the trades were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025.

How many shares and options does Michael Chi hold after the transactions?

After the reported transactions he beneficially owns 291,439 Class A shares and holds 47,106 stock options.

What is the vesting schedule for the options?

The options vest over a 4-year period with 1/48th vesting monthly, beginning on April 1, 2023.